Related Experiment Video
Updated: Jun 20, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications
Guanhua Yu1,2, An Zhang1, Yixiao Liu3
1Department of Colorectal Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Abstract:
C-C motif chemokine ligand 20 (CCL20) is widely expressed in various human tissues and immune cells, playing a critical role in immune cell migration and inflammation. As the sole ligand of CCL20, C-C motif chemokine receptor 6 (CCR6) is a G protein-coupled receptor mainly expressed in immune cells and mediates chemotactic function of CCL20. The CCL20-CCR6 axis actively participates in immune homeostasis and activation. Dysregulation of CCL20-CCR6 axis is regarded as an imperative part of the pathogenic mechanism of autoimmune diseases and cancers, and a multitude of therapeutic strategies have been developed to target CCL20-CCR6 axis. In this review, we comprehensively summarized researches of CCL20-CCR6 axis and introduced the biology and functions of CCL20-CCR6 under normal conditions. We further discussed the pivotal pathogenic roles of CCL20-CCR6 axis in progression of autoimmune diseases as well as cancers from multiple directions. The article also explored recent advancements in the field of CCL20-CCR6 axis inhibition in autoimmune diseases and cancers, shedding light on its potential as a promising therapeutic target. A systematic understanding of CCL20-CCR6 axis in progression of autoimmune diseases and cancers is crucial for realizing the full potential of CCL20-CCR6 axis-based interventions, heralding the promise of improved outcomes for patients.
More Related Videos
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Psychoneuroimmunology: Diabetes and Cancer